Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Novo Nordisk ADR (NYSE: NVO) closed the day trading at $144.49 up 0.57% from the previous closing price of $143.67. In other words, the price has increased by $0.57 from its previous closing price. On the day, 2.59 million shares were traded. NVO stock price reached its highest trading level at $145.36 during the session, while it also had its lowest trading level at $143.43.
Ratios:
For a better understanding of NVO, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 358.11 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 51.94. For the most recent quarter (mrq), Quick Ratio is recorded 0.50 and its Current Ratio is at 0.70. In the meantime, Its Debt-to-Equity ratio is 0.27 whereas as Long-Term Debt/Eq ratio is at 0.17.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on May 30, 2024, initiated with a Buy rating and assigned the stock a target price of $156.
On April 12, 2024, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $163.
On January 23, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $120.Morgan Stanley initiated its Overweight rating on January 23, 2024, with a $120 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVO now has a Market Capitalization of 643867672576 and an Enterprise Value of 661992636416. As of this moment, Novo’s Price-to-Earnings (P/E) ratio for their current fiscal year is 49.89, and their Forward P/E ratio for the next fiscal year is 34.58. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 17.82. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.58 while its Price-to-Book (P/B) ratio in mrq is 44.98. Its current Enterprise Value per Revenue stands at 2.71 whereas that against EBITDA is 5.617.
Stock Price History:
The Beta on a monthly basis for NVO is 0.41, which has changed by 0.78570104 over the last 52 weeks, in comparison to a change of 0.23200047 over the same period for the S&P500. Over the past 52 weeks, NVO has reached a high of $148.15, while it has fallen to a 52-week low of $75.56. The 50-Day Moving Average of the stock is 8.16%, while the 200-Day Moving Average is calculated to be 25.86%.
Shares Statistics:
Over the past 3-months, NVO traded about 3.72M shares per day on average, while over the past 10 days, NVO traded about 3403960 shares per day. A total of 3.38B shares are outstanding, with a floating share count of 3.34B. Insiders hold about 0.02% of the company’s shares, while institutions hold 9.73% stake in the company. Shares short for NVO as of 1718323200 were 4480354 with a Short Ratio of 1.17, compared to 1715731200 on 3706203.
Dividends & Splits
The stock’s 5-year Average Dividend Yield is 1.58. The current Payout Ratio is 36.03% for NVO, which recently paid a dividend on 2024-03-22 with an ex-dividend date of 1711065600. Stock splits for the company last occurred on 2023-09-20 when the company split stock in a 2:1 ratio.
